Discovery of new polymeric materials suitable for prolonging the drug release, and the improvement in therapeutic efficiency and safety achieved by these delivery systems. Now-a-days the technology of controlled release is also being applied to veterinary products. The aim and objective of our current research is to formulate floating and bio adhesive formulations of ciprofloxacin for its controlled delivery to the duodenum which is its best absorption site, thus the oral bioavailability of ciprofloxacin could be improved by using direct compression technique. The experimental results was revealed that the all formulated tablets were of good quality with regard to hardness (3.7 -4 kg/cm2), thickness (0.3 -0.35 cm), density (~ 1 g/cm3), weight variation (1.3-4.2) and drug content (> 90%). As the result of floating capability study increasing the effervescent base of tablets from 5% to 10% significantly lower the lag time of floating (From about 6 min to 1.5 min) as well as floating duration (From about 21 hrs to 10 hrs). Invitro drug release showed (Fig. 1 ) that all formulation released 80% of the ciprofloxacin hydrochloride in 12 hrs study period. It was found that all the formulations were statistically significant (p ≤ 0.05).
Introduction
During the last two decades there has been remarkable increase in interest in controlled release drug delivery system. 1 This has been due to various factor viz. the prohibitive cost of developing new drug entities, expiration of existing international patents, discovery of new polymeric materials suitable for prolonging the drug release, and the improvement in therapeutic efficiency and safety achieved by these delivery systems. Now-a-days the technology of controlled release is also being applied to veterinary products 2 
. Modified Release Dosage
Forms: According to the United States Pharmacopoeia the term 'modified release dosage forms' is used to denote the dosage forms for which the drug release characteristics of time course and/or location are chosen to accomplish therapeutic objectives not offered by the conventional dosage forms. Two types of modified release dosage forms are recognized 3 .
Materials and Methods
Ciprofloxacin Hydrochloride, Carbopol, HPMC K4M, HPMC K4M and SCMC are purchased in Sun 
Method of Preparation
All the bioadhesive floating tablets were fabricated by using direct compression technique. In this case all the bioadhesive polymers and the active ingredients were passed through sieve no. 80 individually. Accurately weighed quantity of Ciprofloxacin powder, polymer, effervescent agent and excipients were thoroughly mixed in a glass mortar-pestle 3 and with help of automatic punching machine by using 12mm flat punch and 3-4 kg/cm2 pressure, tablet were prepared of desired shape, size and hardness.
Determination of floating capacity
Three individual tablets from each formulation were put in an individual flask containing 400ml of 0.1(N) HCL solutions. Then note time in minutes for each tablets to go from the bottom to the top of the flask (floating lag time) and the time for which tablets constantly float on the water surface (duration of floating) were measured. The sample mean and standard deviation were calculated.
Determination of the density of the tablet
The apparent densities of the tablets were calculated from their volumes and masses in triplicate. The volume V of the cylindrical tablets were calculated from their height h and radius r (both determined with a micrometer gauge) using the mathematical equation for a cylinder (V = π × r2 × h) 5.
Determination of drug content in tablets
Three tablets from each batch were selected randomly and transferred to a 100ml volumetric flask filled up with 0.1(N) HCl. Kept it for 48hours then took 1ml from each of volumetric flask and was transferred to the test tubes. Samples were then filtered, suitably diluted and analyzed spectrophotometrically at a suitable wavelength Measurement of bioadhesive strength of the floating formulation The force required to separate the sample disk from a model substrate were measured using a modified balance method as reported by Parodi et al. (1996) . The formulation was fixed to the base and come into contact with mucosal membrane of sheep tongue; the tablets were left for 5 minute for hydrate. A beaker was placed on a moving platform. The beaker was then slowly raised until the substrate came in the contact with the formulation. A preload of 50g was placed into the stopper for 6min so that the adhesion bonding could be established. After this time, the preload was removed and was added at a constant rate. The addition was stopped as soon as the detachment of the two surfaces was obtained.
Determination of In-Vitro Dissolution Study
Dissolution study was carried out in USP-II type dissolution apparatus (paddle type). Dissolution study was performed at 50 rpm in 900 ml 0.1(N) HCl 5ml of sample was withdrawn at a predetermined interval and the volume of dissolution medium was maintained by adding same volume of dissolution medium. The absorption of withdrawn sample was measured.
Results and Discussion
Floating-bioadhesive tablets of ciprofloxacin hydrochloride were mainly prepared by using different polymer like HPMC-K4M, SCMC and Cabopol-934 either alone or in combination. Effervescent base of tablets were prepared by sodium bicarbonate and citric acid in combination. The tablets were fabricated using direct compression technique. The formulated tablets were subjected for various evaluation parameters like hardness, thickness, density, weight variation drug content and floating capability. Our experimental results revealed that all the formulated tablets were of good quality with regard to hardness (3.7 -4 kg/cm2), thickness (0.3 -0.35 cm), density (~ 1 g/cm3), weight variation (1.3-4.2) and drug content (> 90%). As the result of floating capability study showed (Table 2 ) increasing the effervescent base of tablets from 5% to 10% significantly lower the lag time of floating (From about 6 min to 1.5 min) as well as floating duration (From about 21 hrs to 10 hrs). Invitro drug release showed (Fig. 1 ) that all formulation released 80% of the ciprofloxacin hydrochloride in 12 hrs study period. Kinetic models describe drug release from immediate and modified release dosage forms 8. From the result (Table 2) obtained it was observed. That the formulations shows value of r2 over 0.9 for Zero order, Higuchi and First order kinetic model. To predict the mechanism of diffusional release, equation Mt / M∞ = kt n was used considering the n values calculated for the studied tablets (Table 2) , in all cases a non-Fickian mechanism is dominant. Applying ANOVA (using Statplus 2007) to the formulations, it was found that all the formulations were statistically significant (p ≤ 0.05) excellent concept of floating system suffers from a disadvantage that it is effective only when the fluid level in the stomach is sufficiently high; however, as the stomach empties and the tablet is at the pylorus, the buoyancy of the dosage form may be impeded 10. This serious limitation can be overcome by using bioadhesive polymers to enable it to adhere to the mucous lining of the stomach wall Bioadhesive strength was measured by modified balance method as reported by Parodi et al. for the prepared formulations. The result of the bioadhesion test shows that all the formulations poses good bioadhesive strength.
Conclusion
On the basis of present study it was concluded that floating-bioadhesive tablets of ciprofloxacin hydrochloride can increase the gastric residence time as well as bioavailability and thus better patient compliance can be achieved.
